Search results

Skip to results

Type

Type

Last updated

Last updated

Advice programme

Showing 1 result for iloprost

  1. Critical limb ischaemia in peripheral vascular disease: intravenous iloprost (ESUOM24)

    April 2019: This evidence summary has been withdrawn because a product containing intravenous iloprost with a marketing authorisation for treating critical limb ischaemia in peripheral vascular disease is now available in the UK.